Clarius Group, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 833 filers reported holding GLAXOSMITHKLINE PLC in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
Clarius Group, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$273,000
+4.2%
6,269
+5.6%
0.03%
+28.6%
Q1 2022$262,0000.0%5,9340.0%0.02%0.0%
Q4 2021$262,000
+27.8%
5,934
+17.9%
0.02%
-27.6%
Q2 2020$205,000
-6.0%
5,032
-12.7%
0.03%
-29.3%
Q1 2020$218,000
-28.5%
5,766
-10.0%
0.04%
-14.6%
Q4 2019$305,000
+11.3%
6,404
-0.1%
0.05%
-4.0%
Q3 2019$274,000
+22.3%
6,412
+14.7%
0.05%
+11.1%
Q2 2019$224,0005,5900.04%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q2 2020
NameSharesValueWeighting ↓
Sio Capital Management, LLC 325,823$11,557,0006.52%
KAHN BROTHERS GROUP INC 1,139,163$40,406,111,0006.35%
Chubb Ltd 400,000$14,188,0006.18%
Healthcare Value Capital, LLC 50,000$1,774,0005.40%
CLARK ESTATES INC/NY 650,000$23,056,0003.81%
PVG ASSET MANAGEMENT CORP 220,450$7,819,361,0003.57%
Martin Capital Partners, LLC 88,195$3,128,0003.25%
Camber Capital Management LP 1,500,000$53,205,0002.60%
EQUITY INVESTMENT CORP 2,090,120$74,137,0002.47%
Keystone Financial Planning, Inc. 129,102$4,579,0002.44%
View complete list of GLAXOSMITHKLINE PLC shareholders